NDC codes

FDA NDC Directory
Product NDC (as listed)81806-177Labeler and product segments. Claims need a package NDC.
Product NDC at billing width81806-0177Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
81806-177-30818060177301 BOTTLE in 1 CARTON (81806-177-30) / 30 TABLET in 1 BOTTLEMarketed from Jun 12, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Jaythari
Generic name (nonproprietary)
deflazacort
Active ingredients
Deflazacort — 36 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 219254
Marketing start
Listing expires
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 81806-177_5a0e8719-3843-f24e-e063-6294a90a09b2SPL ID 5a0e8719-3843-f24e-e063-6294a90a09b2SPL set ID 3542a1e3-acfd-6b9a-e063-6394a90a9466RxCUI 153098, 153880, 1870954, 1870958, 2716704, 2716706, 2716708, 2716710UNII KR5YZ6AE4B
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N481806017730 followed by a unit qualifier and the quantity

Package 81806-0177-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. JAYTHARI is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219254

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219254
ProductStrengthForm · routeLabelerProduct NDC
DeflazacortDeflazacort 30 mg/1TabletOralAvKARE73190-070
DeflazacortDeflazacort 6 mg/1TabletOralAvKARE73190-068
DeflazacortDeflazacort 18 mg/1TabletOralAvKARE73190-069
DeflazacortDeflazacort 36 mg/1TabletOralAvKARE73190-071
JaytharideflazacortDeflazacort 18 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-175
DeflazacortDeflazacort 6 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-2051
JaytharideflazacortDeflazacort 6 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-174
JaytharideflazacortDeflazacort 30 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-176
DeflazacortDeflazacort 18 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-2052
DeflazacortDeflazacort 30 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-2053
DeflazacortDeflazacort 36 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-2054
DeflazacortDeflazacort 36 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-208
DeflazacortDeflazacort 6 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-204
DeflazacortDeflazacort 18 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-206
DeflazacortDeflazacort 30 mg/1TabletOralDoppel Farmaceutici S.r.l.81806-207
JaytharideflazacortDeflazacort 36 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-1752
JaytharideflazacortDeflazacort 6 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-1749
JaytharideflazacortDeflazacort 18 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-1750
JaytharideflazacortDeflazacort 30 mg/1TabletOralZydus Pharmaceuticals (USA) Inc.70710-1751

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Jaythari (deflazacort) NDC 81806-177 | Med-Code